Tranquillizers, Sedatives and Hypnotics: Forensic Analysis

Barbiturates, benzodiazepines and Z-drugs all act at the GABA-A receptor, a chloride-channel ionotropic receptor in the CNS. Channel opening lets chloride in, hyperpolarises the neuron and drops firing rate. The three classes potentiate the receptor at different sites, which is why their toxicology profiles differ.

Barbiturates. Cyclic derivatives of barbituric acid. They prolong the chloride-channel open time at GABA-A, and at higher doses directly open the channel without GABA. That direct-agonist behaviour explains why barbiturate overdose has no ceiling on CNS depression and is far more lethal than a BZD equivalent. Sub-classes by duration of action: long (phenobarbital, anti-epileptic), intermediate (amobarbital), short (secobarbital, pentobarbital), ultrashort (thiopental, methohexital, IV anaesthetics).

Benzodiazepines (BZDs). Fused benzene plus seven-member diazepine ring. Allosteric modulators that need GABA to be present and increase the frequency of chloride-channel opening. Pure BZD overdose rarely kills an adult on its own; the cause of death is almost always combination with alcohol, opioids or barbiturates. The principal Indian casework agents are: alprazolam (anxiety and the most common agent in stupefying-robbery cases), diazepam (anxiety, status epilepticus), lorazepam (status epilepticus, premedication), nitrazepam (hypnotic, Schedule H1) and clonazepam (epilepsy, panic disorder). Antidote: flumazenil, a competitive antagonist at the BZD site.

Z-drugs. Zolpidem, zopiclone, eszopiclone. Not benzodiazepines structurally but bind the alpha-1 subunit of GABA-A selectively. Same drink-spiking potential as alprazolam in Indian casework. Zolpidem is Schedule H1.

Other hypnotics. Chloral hydrate (the original "Mickey Finn"), glutethimide (largely obsolete), methaqualone (Mandrax, listed under the NDPS Act).

Tranquillizers (major). Phenothiazines (chlorpromazine, promazine, thioridazine, fluphenazine) and butyrophenones (haloperidol). Dopamine D2 antagonists rather than GABA-A drugs, but examiners groups them under this bullet. Colour-screen reagent for this group is FPN or Forrest, not Zwikker.

The Indian SFSL workflow for a suspected sedative-hypnotic mirrors the signs, symptoms and antidotes of common poisonsworkup. Viscera or biological fluid is extracted via the classical pH-controlled liquid-liquid pulls (acidic, neutral, alkaline), and the concentrate runs through a layered screen before hyphenated-instrument confirmation.

Colour (spot) tests. A microgram of dried extract on a porcelain spot plate gets a drop of reagent. The classical barbiturate trio is Zwikker (cobalt nitrate plus isopropylamine, violet), Koppanyi-Zwikker (same chemistry, modified order of addition) and Dille-Koppanyi (cobalt acetate plus isopropylamine, blue-violet). Cobalt complexes the deprotonated barbiturate ring. For phenothiazines, FPN (ferric chloride plus perchloric plus nitric acid) gives a deep red with chlorpromazine and most ring-substituted phenothiazines; Forrest is a close variant. Screens are sensitive but not specific; a negative does not exclude the class.

TLC. Silica gel 60 F254 with chloroform-methanol mobile phase (90:10 to 80:20), UV-254 visualisation, then iodoplatinate (brown-purple) or Dragendorff (orange-red) spray. Rf plus visualisation colour discriminates the class. The book chapter on acidic, neutral and alkaline drug analysiscovers the planar separation.

Immunoassay screening. ELISA, EMIT and CEDIA kits with class-level monoclonal antibodies. The BZD kit cross-reacts poorly with clonazepam, lorazepam and 7-aminoflunitrazepam, so a negative immunoassay never closes a stupefying-substance case.

Confirmation: GC-MS, LC-MS-MS, HPLC-DAD. GC-MS in EI mode handles free, thermostable drugs (phenobarbital, secobarbital, diazepam, chlorpromazine). BZDs often need BSTFA silylation for clean GC peaks, which is why LC-MS-MS with electrospray has largely replaced GC-MS for the class. LC-MS-MS also catches the glucuronide metabolites (oxazepam-glucuronide, lorazepam-glucuronide) that dominate in urine. HPLC-DAD with library spectral match is a defensible secondary confirmation. The hyphenated techniques chaptercovers the instrument detail.

Two practical cautions. First, cobalt-amine reagents only work on the ring NH of the barbiturate, so N-methylated barbiturates (methohexital, hexobarbital) give a weak or absent reaction. Second, FPN and Forrest are specific to the phenothiazine nucleus, so haloperidol (butyrophenone) and clozapine (dibenzodiazepine) are FPN-negative despite being clinically grouped with phenothiazine antipsychotics.

Metabolic identification is central to forensic BZD casework, and the dominant target in urine is the glucuronide conjugate. Phase I CYP450 oxidation produces an active or inactive metabolite, then phase II UGT glucuronidation gives a polar conjugate the kidney excretes.

Barbiturates. Hepatic CYP oxidation to hydroxy and carboxy metabolites, then glucuronide conjugation. Phenobarbital has a long half-life (80 to 120 hours) and is partly excreted unchanged, which is why urine alkalinisation with sodium bicarbonate is the classical management of phenobarbital overdose.

Benzodiazepines. Three patterns. Long-acting BZDs (diazepam) undergo N-demethylation to nordiazepam, hydroxylation to oxazepam, then glucuronidation to oxazepam-glucuronide. Intermediate BZDs (lorazepam, oxazepam) are directly glucuronidated without phase I. Triazolo-BZDs (alprazolam, triazolam) are 4-hydroxylated by CYP3A4 to alpha-hydroxyalprazolam, then glucuronidated. A BZD urine screen must include beta-glucuronidase digestion (37 degrees, two hours) before LC-MS-MS or the lab will under-report.

Z-drugs. Zolpidem is CYP3A4-oxidised to zolpidem phenyl-4-carboxylic acid. Detected in urine for up to 60 hours (with the major metabolite zolpidem phenyl-4-carboxylic acid detectable up to 72 hours), in blood for approximately 6 to 20 hours.

Phenothiazines. Chlorpromazine has more than 100 documented metabolites, including the sulphoxide and various ring-hydroxylated and N-demethylated forms. Long detection window in hair and urine.

The book chapter on drug metabolism and metabolite identificationcovers the enzymology in depth.

Schedule H, H1 and X (Drugs and Cosmetics Rules 1945). Schedule H lists prescription drugs (most BZDs, phenobarbital, chlorpromazine, haloperidol). Schedule H1 (added in 2013, Rule 65(11A)) is a subset that requires the chemist to keep a separate register for three years with prescriber, patient and quantity. The sedative-hypnotics on Schedule H1 to memorise are alprazolam, nitrazepam and zolpidem. The H1 label carries a red vertical line. Schedule X covers high-risk drugs (cocaine, amphetamine, secobarbital, methaqualone); dispensing requires a duplicate prescription, one copy retained for two years.

NDPS Act 1985.Methaqualone (Mandrax) is listed as a psychotropic substance in the NDPS Schedule, with small-quantity and commercial-quantity thresholds setting the punishment. Some barbiturates (secobarbital, amobarbital, pentobarbital) and some BZDs also appear, mirroring the UN Convention on Psychotropic Substances 1971. The book chapter on Indian poison laws and the Drugs and Cosmetics Actlays out the schedules side by side.

BNS 2023 Section 328 (formerly IPC 328)."Causing hurt by means of poison etc. with intent to commit an offence." Punishment up to ten years and a fine. The forensic lab proves the drug was present in the victim's blood or the residual drink, at a concentration pharmacologically plausible for stupefaction.

Indian casework anchors. Alprazolam-laced lassi and cold-drink robberies on long-distance trains (the Tamil Nadu Express, the Bangalore-Howrah corridor) have produced repeat convictions for itinerant gangs since the mid-2000s. The Mumbai-Pune highway "ATM gang" cases involved dhaba hosts spiking truck drivers with alprazolam. AIIMS Forensic Medicine and CFSL Hyderabad casework cite the modal presentation as unconscious or amnesic victim, empty wallet, half-finished beverage, and an alprazolam blood concentration in the 50 to 300 ng/mL range (well above the 10 to 50 ng/mL therapeutic range, consistent with 2 to 6 mg crushed into the drink).

Therapeutic versus toxic concentration. A positive blood concentration is not by itself proof of stupefaction. The defence will produce a prescription showing chronic BZD use, in which case a "high" trough level may be physiological. The lab reports the concentration, matrix, sampling time and the published reference range; expert opinion under BSA Section 39 ties the number to clinical effect.

False positives in the screen. FPN gives a weaker pink with imipramine and amitriptyline (TCAs) and an inexperienced analyst can mis-call a TCA as a phenothiazine. Immunoassay BZD kits miss clonazepam and 7-aminoflunitrazepam and over-call oxaprozin and sertraline. Never close a case on the screen alone; GC-MS or LC-MS-MS confirmation with a deuterated internal standard is what the court reads.

Sample window. Alprazolam and zolpidem have short half-lives (6 to 12 hours), so a blood draw beyond 24 hours from the alleged dosing event often misses the drug. Urine extends to three to five days, hair to weeks. Chain of custody from hospital collection to SFSL receipt must be intact, every transfer logged.